Data imputation [General Sta­tis­tics]

posted by Helmut Homepage – Vienna, Austria, 2020-07-02 09:15 (120 d 03:53 ago) – Posting: # 21635
Views: 1,905

Hi Martin,

» […] adequate handling would require some modeling which seems to be in contradiction to regulatory thinking as NCA is clearly favored in BA/BE studies.
Yep. The EMA’s BE-GL states:

Non-compartmental methods should be used for determination of pharmacokinetic parameters in bioequivalence studies. The use of compartmental methods for the estimation of parameters is not acceptable.


» However, I would like to bring a recent paper on this topic to your attention: […]

Why am I not surprised that Thomas recommends kernel density imputation? ;-)
However, PK modeling is not applied. \(\small{\widehat{AUC}}\) is still obtained by NCA, right?
—
Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,180 posts in 4,415 threads, 1,476 registered users;
online 8 (1 registered, 7 guests [including 3 identified bots]).
Forum time: Friday 13:08 UTC (Europe/Vienna)

The idea is to try and give all the information to help others
to judge the value of your contribution;
not just the information that leads to judgment
in one particular direction or another.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5